BPA

BPA Exposure in U.S.-Approved Levels May Alter Insulin Response in Non-Diabetic Adults

Thu, 09/13/2018 - 1:31pm -- yountj
Frederick vom Saal

Fred vom Saal and his team found that the Food and Drug Administration-approved “safe” daily exposure amount of BPA may be enough to have implications for the development of Type 2 diabetes and other metabolic diseases.

COLUMBIA, Mo. – In a first study of its kind study, researchers have found that a common chemical consumers are exposed to several times a day may be altering insulin release. Results of the study, led by scientists at the University of Missouri, indicate that the Food and Drug Administration-approved “safe” daily exposure amount of BPA may be enough to have implications for the development of Type 2 diabetes and other metabolic diseases.

Tags: 
BPA
FDA
diabetes
insulin
Subscribe to RSS - BPA